Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Córdoba JF"'
Autor:
Peressini M; Tumor Microenvironment and Immunotherapy Research Group, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain., Garcia-Campelo R; Department of Medical Oncology, Hospital Universitario de A Coruña, A Coruña, Spain., Massuti B; Department of Medical Oncology, Hospital General Universitario de Alicante, Alicante, Spain., Martí C; Department of Medical Oncology, Hospital Universitario Sant Joan de Reus, Tarragona, Spain., Cobo M; Department of Medical Oncology, UGC intercentros de Oncología Médica, Hospitales Universitarios Regional y Virgen de la Victoria, IBIMA, Málaga, Spain., Gutiérrez V; Department of Medical Oncology, Complejo Hospitalario Regional de Málaga, Málaga, Spain., Dómine M; Department of Medical Oncology, Hospital Universitario Fundación Jimenez Díaz, Madrid, Spain., Fuentes J; Department of Medical Oncology, Hospital Universitario Virgen de Valme, Sevilla, Spain., Majem M; Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., de Castro J; Department of Medical Oncology, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain., Córdoba JF; Department of Medical Oncology, Hospital Universitario Arnau de Villanova, Lérida, Spain., Diz MP; Department of Medical Oncology, Complejo Asistencial Universitario de León, León, Spain., Isla D; Department of Medical Oncology, Hospital Universitario Lozano Blesa, Zaragoza, Spain., Esteban E; Department of Medical Oncology, Hospital Universitario Central de Asturias, Asturias, Spain., Carcereny E; Department of Medical Oncology, Instituto Catalán de Oncología de Badalona, Badalona-Applied Research Group in Oncology (B-ARGO), Barcelona, Spain., Vila L; Department of Medical Oncology, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Barcelona, Spain., Moreno-Vega A; Department of Medical Oncology, Hospital Universitario Reina Sofia, Córdoba, Spain., Ros S; Department of Medical Oncology, Hospital Universitario Virgen de La Arrixaca, Murcia, Spain., Moreno A; Department of Medical Oncology, Hospital de Galdakao, Vizcaya, Spain., García FJ; Department of Medical Oncology, Hospital Universitario Son Llatzer, Mallorca, Spain., Huidobro G; Department of Medical Oncology, Hospital Universitario Álvaro Cunqueiro, Vigo, Spain., Aguado C; Department of Medical Oncology, Hospital Universitario Clínico San Carlos, Madrid, Spain., Cebey-López V; Department of Medical Oncology, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain., Valdivia J; Department of Medical Oncology, Hospital Universitario Virgen de las Nieves, Granada, Spain., Palmero R; Department of Medical Oncology, Instituto Catalán de Oncología de Hospitalet de Llobregat, Barcelona, Spain., Lianes P; Department of Medical Oncology, Hospital de Mataró, Barcelona, Spain., López-Brea M; Department of Medical Oncology, Hospital Universitario Marqués de Valdecilla, Santander, Spain., Vidal OJ; Department of Medical Oncology, Hospital Universitario La Fe, Valencia, Spain., Provencio M; Department of Medical Oncology, Hospital Universitario Puerta de Hierro, Madrid, Spain., Arriola E; Department of Medical Oncology, Hospital del Mar, Barcelona, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain., Baena J; Tumor Microenvironment and Immunotherapy Research Group, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain., Herrera M; Tumor Microenvironment and Immunotherapy Research Group, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain., Bote H; Tumor Microenvironment and Immunotherapy Research Group, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain., Molero M; Tumor Microenvironment and Immunotherapy Research Group, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain., Adradas V; Tumor Microenvironment and Immunotherapy Research Group, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain., Ponce-Aix S; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain., Nuñez-Buiza A; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain., Ucero Á; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Department of Physiology, Complutense University, Madrid, Spain., Hernandez S; Department of Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain., Lopez-Rios F; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Department of Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Legal Medicine, Psychiatry and Pathology, Complutense University, Madrid, Spain., Conde E; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Department of Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Legal Medicine, Psychiatry and Pathology, Complutense University, Madrid, Spain., Paz-Ares L; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Department of Physiology, Complutense University, Madrid, Spain.; Department of Medicine, Complutense University, Madrid, Spain., Zugazagoitia J; Tumor Microenvironment and Immunotherapy Research Group, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jul 15; Vol. 30 (14), pp. 3036-3049.
Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study.
Autor:
Provencio M; Medical Oncology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., Rodríguez-Abreu D; Medical Oncology Department, Hospital Universitario Insular de Gran Canaria, Las Palmas, Spain., Ortega AL; Medical Oncology Department, Hospital Universitario de Jaén, Jaén, Spain., Serrano G; Medical Oncology Department, Hospital Universiario Infanta Leonor, Madrid, Spain., Aguado C; Medical Oncology Department, Hospital Clínico San Carlos, Madrid, Spain., Franco F; Medical Oncology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., Gutierrez V; Medical Oncology Department, Hospital Universitario Regional de Málaga, Málaga, Spain., López Vivanco G; Medical Oncology Department, Hospital Universitario Cruces, Barakaldo, Spain., Guirado M; Medical Oncology Department, Hospital General Universitario de Elche, Alicante, Spain., Benítez G; Medical Oncology Department, Hospital Universitario Insular de Gran Canaria, Las Palmas, Spain., Estival A; Catalan Institute of Oncology, Hospital Universitari Germans Trias i Pujol, B-ARGO, IGTP, Badalona, Spain., Calvo V; Medical Oncology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., Jiménez B; Medical Oncology Department, Hospital Universitario HM Sanchinarro, Madrid, Spain., Arasanz H; Medical Oncology Department, Complejo Hospitalario Navarra-Navarrabiomeed, Pamplona, Spain., Coves J; Medical Oncology Department, Hospital Universitari Son LLàtzer, Palma de Mallorca, Spain., Majem M; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Massutí B; Medical Oncology Department, Hospital General Universitario de Alicante, Alicante, Spain., Vázquez S; Medical Oncology Department, Hospital Universitario Lucus Augusti, Lugo, Spain., Juan-Vidal O; Medical Oncology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Collazo-Lorduy A; Medical Oncology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., Gozálvez CL; Medical Oncology Department, Hospital Universitari Sant Joan de Reus, Reus, Spain., Del Barco E; Medical Oncology Department, Hospital Clínico Universitario de Salamanca, Salamanca, Spain., Rosero A; Medical Oncology Department, Hospital Universitario Infanta Cristina, Madrid, Spain., Bosch-Barrerra J; Medical Oncology Department, Institut Català d'Oncologia, Girona, Spain., Moreno MA; Medical Oncology Department, Hospital Universitario de Puerto Real, Cádiz, Spain., Mielgo-Rubio X; Medical Oncology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain., Villa JC; Medical Oncology Department, Hospital General Universitario Ciudad Real, Ciudad Real, Spain., López-Martin A; Medical Oncology Department, Hospital Universitario Severo Ochoa, Madrid, Spain., Córdoba JF; Medical Oncology Department, Hospital Universitario Arnau de Vilanova, Lleida, Spain., de Asís Aparisi F; Medical Oncology Department, Hospital General Universitario de Valencia, Valencia, Spain., Zafra M; Medical Oncology Department, Hospital General Universitario Morales Messeguer, Murcia, Spain., Mosquera J; Medical Oncology Department, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain., Pérez Altozano J; Medical Oncology Department, Hospital Virgen de los Lirios, Alicante, Spain., Nadal E; Medical Oncology Department, Institut Català d'Oncologia, Hospitalet de Llobregat, Barcelona, Spain., Catot S; Medical Oncology Department, Altaia, Xarxa Assistencial Universitaria Manresa, Barcelona, Spain., Balsalobre J; Medical Oncology Department, Hospital General Universitario Santa Lucia, Cartagena, Murcia, Spain., de Portugal T; Medical Oncology Department, Complejo Hospitalario de Zamora, Zamora, Spain., Martín P; Medical Oncology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain., Cuesta de Juan S; Laboratorio Central, Eurofins Megalab, Madrid, Spain., Cobo M; Medical Oncology Department, Hospital Universitario Regional de Málaga, Málaga, Spain.
Publikováno v:
Translational lung cancer research [Transl Lung Cancer Res] 2022 Jan; Vol. 11 (1), pp. 53-63.